Benitec Biopharma Inc. Financial Ratios — BNTC Stock

Profitability (AUD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	-21.73	-36.99	-128.04	-31.93	-61.27	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-20.72	-33.92	-107.49	-27.1	-51.68	14.95	-53.69	-84.22	-133.14	-374.86	-76.76	-49.96
Return on Capital (%)	- -	- -	- -	- -	- -	- -	-5.42	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	17.01	- -	- -	- -	- -	- -	- -
Gross Margin (%)	67.73	93.31	96.3	70.04	18.32	-19.31	96.23	290.72	-108.47	87.67	100	- -	- -
EBITDA Margin (%)	-1,234.45	-1,234.45	-965.59	-4,606.25	-1,617.9	-3,143.92	23.73	-8,151.55	-22,325.42	-23,920.55	-24,933.33	- -	- -
Operating Margin (%)	-1,234.45	-1,234.45	-965.59	-4,606.25	-1,702.7	-3,143.92	22.36	-8,537.11	-23,044.07	-24,457.53	-25,441.33	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	100.35	- -	- -	- -	- -	4,545.33	- -
Pretax Margin (%)	-1,253.01	-1,253.01	-1,064.66	-5,340.09	-1,708.71	-3,079.37	22.59	-8,529.9	-23,528.81	-24,942.47	-26,082.67	- -	- -
Profit Margin (%)	-1,177.09	-1,177.09	-1,064.66	-5,340.09	-1,708.71	-3,079.37	22.59	-8,529.9	-23,528.81	-24,942.47	-26,082.67	- -	- -
Net Income to Common Margin (%)	-1,177.09	-1,177.09	-1,064.66	-5,340.09	-1,708.71	-3,079.37	22.59	-8,529.9	-23,528.81	-24,942.47	-26,082.67	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	-21.73	-36.99	-128.04	-31.93	-61.27	- -	- -	- -	- -	- -	- -	- -

Credit (AUD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	- -	1
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	- -
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	-0.05	-0.02	-0.05	-0.03	-0.01	-0.02
Net Debt/EBITDA	4.25	4.25	2.09	0.85	3.22	1.35	-5.73	1.24	1.5	0.23	0.13	2.3	2.36
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	-0.05	-0.02	-0.05	-0.03	-0.01	-0.02
Net Debt/EBIT	4.25	4.25	2.09	0.85	3.06	1.35	-6.09	1.18	1.45	0.23	0.13	2.26	2.34
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	-2,195.33	-545.69	-566.67	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	-2,232.17	-546.09	-566.7	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	-2,266	-557.94	-578.21	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	95.37	95.37	85.58	81.81	87.5	80.85	-565.99	-1,006.61	-608.63	-2,483.29	-3,760.95	-364.41	-229.11
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	2.08	- -	19.4	140.59	- -	0.51
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.18	- -	-0.38	-0.17	- -	-0.22
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	1.84	- -	9.36	6.36	- -	0.5
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	3.96	1.06	28.14	276.73	0.6	0.87
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.35	-0.16	-0.55	-0.33	-0.15	-0.37
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	3.5	1	13.58	12.52	0.54	0.85
Net Debt to Equity	-93.49	-93.49	-91.24	-96.78	-80.79	-85.81	-94.72	-95.73	-98.8	-140.94	-1,226.24	-107.66	-100.46
Net Debt/Capital (%)	-2,034.98	-2,034.98	-41,107.55	931.05	-707.16	-1,378.32	12.62	7.78	13.21	2.68	1.46	21.12	30.07
EBITDA	-7	-7	-8	-16	-4	-9	3	-8	-13	-17	-19	-22	-41
EBITDA-CapEx	-7	-7	-8	-16	-4	-9	2	-8	-13	-17	-19	-22	-41
Operating Income (Loss)	-7	-7	-8	-16	-4	-9	3	-8	-14	-18	-19	-22	-42

Liquidity (AUD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	32.84	32.84	13.27	17.64	15.44	6.33	5.96	8.63	14.44	1.6	0.62	10.33	54.24
Current Ratio	36.07	36.07	15.26	18.73	19.7	8.2	7.1	9.51	15.05	1.9	0.94	10.49	54.67
Quick Ratio	32.96	32.96	13.42	18.58	19.36	8	6.92	8.68	14.46	1.61	0.64	10.38	54.26
CFO/Avg Current Liab	- -	-10.95	-8.98	-19.89	-10.14	- -	2.12	-3.99	-10.25	-8.15	-5.53	-4.36	-7.01
Common Equity/Total Assets	95.37	95.37	85.58	81.81	87.5	80.85	-565.99	-1,006.61	-608.63	-2,483.29	-3,760.95	-364.41	-229.11
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	2.08	- -	19.4	140.59	- -	0.51
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.18	- -	-0.38	-0.17	- -	-0.22
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	1.84	- -	9.36	6.36	- -	0.5
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	3.96	1.06	28.14	276.73	0.6	0.87
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.35	-0.16	-0.55	-0.33	-0.15	-0.37
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	3.5	1	13.58	12.52	0.54	0.85
CFO/Total Liabilities	-1,063.76	-1,077.93	-769.56	-2,569.81	-931.57	- -	181.37	-558.56	-937.33	-514.36	-422.62	-391.03	-1,026.9
CFO/CapEx	-317.47	-321.7	-25.02	-79.12	-63.19	- -	11.86	-79.32	-58.06	-1,223	-18,012	-108.4	-1,310.44
Altman's Z-Score	-3.43	62.95	23.4	-4.78	2.84	-3.83	-3.69	-11.85	-1.54	-42.32	-66.02	10.07	107.24

Working Capital (AUD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	4.6	6.74	0.68	0.51	2.68	8.23	0.07	1.4	5.21	2.59	- -	- -
Days Sales Outstanding	- -	79.42	54.15	538.8	719.6	136.34	44.36	5,207.84	259.83	70	141.13	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	0.07	0.05	0.21	0.78	1.18	0.46	-0.21	0.44	0.03	- -	- -	- -
Accounts Payable Turnover Days	- -	5,148.39	6,676.58	1,731.23	467.54	308.36	797.15	-1,732.27	824.96	14,113.33	- -	- -	- -
Cash Conversion Cycle	- -	-5,068.97	-6,622.43	-1,192.43	252.06	-172.02	-752.8	6,940.11	-565.13	-14,043.33	- -	- -	- -
Inventory to Cash Days	- -	79.42	54.15	538.8	719.6	136.34	44.36	5,207.84	259.83	70	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (AUD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	99	62	9	16	21	10	8	18	9	6	128	424
- Cash & Cash Equivalents	29	30	17	14	13	12	16	10	20	4	2	51	98
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	- -	1
Enterprise Value	-29	70	45	-5	3	9	-6	-1	-1	6	4	78	327
Total Capital	30	31	17	12	15	13	-109	-116	-130	-148	-167	-190	-227
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.35	-0.16	-0.55	-0.33	-0.15	-0.37
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	-0.31	-0.16	0.13	0.15	- -	- -
EV/Sales	- -	124.24	54.58	- -	11.24	32.78	12.8	23.77	81.21	85.32	49.45	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	53.95	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	57.25	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	30.87	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	149.28	28.47	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	99	62	9	16	21	10	8	18	9	6	128	424
Diluted Enterprise Value	-29	70	45	-5	3	9	-6	-1	-1	6	4	78	327
EV per Share	- -	3,944.87	1,998.31	- -	83.59	220.57	172.6	38.38	18.96	12.96	2.68	4.24	9.02
TTM Sales	1	1	1	- -	- -	- -	12	- -	- -	- -	- -	- -	- -
TTM EBITDA	-7	-7	-8	-16	-4	-9	3	-8	-13	-17	-19	-22	-41
TTM Operating Income	-7	-7	-8	-16	-4	-9	3	-8	-14	-18	-19	-22	-42
TTM Cash Flow to Firm	-9	-10	-10	-20	-8	- -	5	-8	-13	-16	-18	-19	-24
TTM Free Cash Flow to Firm	-9	-10	-9	-20	-8	- -	5	-7	-13	-16	-18	-19	-24

Multiples (AUD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	-10.3	-6.66	-0.45	-1.99	343.44	1.85	-1.09	-1.45	-0.6	-0.31	-6.68	-17.97
EV/EBIT	- -	- -	- -	- -	- -	- -	57.25	- -	- -	- -	- -	- -	- -
Enterprise Value	-29	70	45	-5	3	9	-6	-1	-1	6	4	78	327
Low Price	- -	5,406	2,366.4	311.1	306	471.75	178.5	70.38	39.1	12.58	2.23	1.86	6.91
EV/Sales	- -	124.24	54.58	- -	11.24	32.78	12.8	23.77	81.21	85.32	49.45	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	53.95	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	3.69	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	-15.5	-9.46	-1.91	-3.99	-3.32	9.99	-1.07	-1.44	-1.23	-0.43	-3.73	-10.91
Price/Earnings High	- -	-15.83	-15.18	-5.45	-10.99	-5.17	24.14	-2.44	-3.25	-2.15	-1.43	-9.03	-16.38
Price/Earnings Low	- -	-14.46	-6.07	-0.47	-2.41	-2.28	3.45	-0.51	-0.71	-0.33	-0.16	-1.57	-6.6
Price/Book Value	- -	3.21	3.7	0.74	1.06	1.65	-0.09	-0.07	-0.14	-0.06	-0.03	-0.67	-1.86
Price/Book Value Average	- -	3.32	4.98	2.91	1.14	2.24	-0.24	-0.08	-0.15	-0.15	-0.05	-0.43	-1.81
Price/Book Value High	- -	3.39	8	8.29	3.15	3.49	-0.58	-0.17	-0.35	-0.26	-0.17	-1.03	-2.72
Price/Book Value Low	- -	3.09	3.2	0.71	0.69	1.54	-0.08	-0.04	-0.08	-0.04	-0.02	-0.18	-1.1
Price/Tangible Book Value	- -	3.15	3.38	0.64	0.98	1.52	0.58	0.79	0.91	3.29	27.85	2.72	4.35
Price/Tangible Book Value Average	- -	3.25	4.56	2.52	1.06	2.06	1.57	0.86	1	7.8	41.43	1.71	4.25
Price/Tangible Book Value High	- -	3.32	7.32	7.17	2.91	3.21	3.79	1.97	2.25	13.55	138.79	4.16	6.38
Price/Tangible Book Value Low	- -	3.04	2.93	0.62	0.64	1.41	0.54	0.41	0.49	2.1	15.3	0.72	2.57
Price/Sales	- -	176.68	74.74	26.04	63.41	75.41	0.83	83.27	309.41	129.85	75.02	- -	- -
Price/Sales Average	- -	182.46	100.71	102.14	68.14	102.2	2.26	90.86	339.48	308.02	111.57	- -	- -
Price/Sales High	- -	186.31	161.6	290.88	187.84	159.12	5.45	208.45	763.71	535.08	373.8	- -	- -
Price/Sales Low	- -	170.25	64.64	25.05	41.13	70.11	0.78	43.58	167.45	82.84	41.2	- -	- -
Price/Cash Flow	- -	-10.26	-6.39	-0.45	-1.95	- -	2.01	-1.07	-1.42	-0.6	-0.31	-6.62	-17.96
Price/Cash Flow Average	- -	-10.6	-8.62	-1.75	-2.1	- -	5.44	-1.17	-1.56	-1.41	-0.46	-4.18	-17.54
Price/Cash Flow High	- -	-10.82	-13.82	-4.99	-5.79	- -	13.15	-2.68	-3.51	-2.46	-1.56	-10.13	-26.33
Price/Cash Flow Low	- -	-9.89	-5.53	-0.43	-1.27	- -	1.88	-0.56	-0.77	-0.38	-0.17	-1.76	-10.61
Price/Free Cash Flow Average	- -	-10.63	-8.97	-1.77	-2.13	465.43	5.02	-1.18	-1.59	-1.42	-0.46	-4.22	-17.56
Price/Free Cash Flow High	- -	-10.86	-14.4	-5.05	-5.88	724.67	12.12	-2.72	-3.57	-2.46	-1.56	-10.22	-26.35
Price/Free Cash Flow Low	- -	-9.92	-5.76	-0.44	-1.29	319.28	1.73	-0.57	-0.78	-0.38	-0.17	-1.78	-10.62
EV/Sales Average	- -	130.02	80.56	62.85	15.96	59.64	0.9	38.15	8.02	263.48	86	- -	- -
EV/Sales High	- -	133.87	141.44	251.59	135.67	116.57	4.09	111.58	432.25	490.54	348.23	- -	- -
EV/Sales Low	- -	117.81	44.48	- -	2.53	27.55	11.88	- -	- -	38.3	15.63	- -	- -
EV/EBITDA Average	4.25	-10.53	-8.34	-1.36	-0.99	-1.9	3.77	0.07	-0.04	-1.1	-0.34	-1.37	-7.66
EV/EBITDA High	4.25	-10.84	-14.65	-5.46	-8.39	-3.71	17.24	-1.37	-1.94	-2.05	-1.4	-6.59	-12.67
EV/EBITDA Low	4.25	-9.54	-4.61	0.31	0.68	-0.88	-2.45	0.65	0.73	-0.16	-0.06	0.74	-3.71
EV/EBIT Average	4.25	-10.53	-8.34	-1.36	-0.94	-1.9	4.01	0.07	-0.03	-1.08	-0.34	-1.35	-7.59
EV/EBIT High	4.25	-10.84	-14.65	-5.46	-7.97	-3.71	18.29	-1.31	-1.88	-2.01	-1.37	-6.49	-12.55
EV/EBIT Low	4.25	-9.54	-4.61	0.31	0.65	-0.88	-2.6	0.62	0.71	-0.16	-0.06	0.73	-3.67
Last Price	- -	5,610	2,736.15	323.34	471.75	507.45	190.99	134.47	72.25	19.72	4.06	6.99	11.7
High Price	- -	5,916	5,916	3,612.07	1,397.4	1,070.74	1,249.5	336.6	178.33	81.26	20.23	10.7	17.15
Enterprise Value Average	-29	73	67	22	4	17	10	-1	- -	19	6	30	317
Enterprise Value High	-29	75	117	87	35	32	47	11	26	36	26	146	524
Enterprise Value Low	-29	66	37	-5	-3	8	-7	-5	-10	3	1	-16	153

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	- -	- -	- -	- -	1	1	1	- -	- -	- -	2	10	26
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	18	36
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	18	36
Revenue per Share	123.14	31.75	36.61	12.42	7.44	6.73	229.2	1.61	0.23	0.15	0.05	- -	- -
EBITDA per Share	-1,520.04	-391.98	-353.49	-572	-120.36	-211.56	54.39	-131.63	-52.13	-36.33	-13.49	-1.21	-1.14
Operating Income per Share	-1,520.04	-391.98	-353.49	-572	-126.67	-211.56	51.25	-137.86	-53.81	-37.14	-13.77	-1.22	-1.15
Basic EPS, GAAP	-1,449.41	-373.76	-389.77	-663.12	-127.11	-207.21	51.77	-137.74	-54.94	-37.88	-14.12	-1.18	-1.05
Basic EPS from Cont Ops	-1,449.41	-373.76	-389.77	-663.12	-127.11	-207.21	51.77	-137.74	-54.94	-37.88	-14.12	-1.18	-1.05
Diluted EPS, GAAP	-1,449.41	-373.76	-389.77	-663.12	-127.11	-207.21	51.77	-137.74	-54.94	-37.88	-14.12	-1.18	-1.05
Diluted EPS from Cont Ops	-1,449.41	-373.76	-389.77	-663.12	-127.11	-207.21	51.77	-137.74	-54.94	-37.88	-14.12	-1.18	-1.05
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-2,091.83	-546.61	-427.94	-724.2	-241.41	- -	95.05	-125.44	-50.79	-33.08	-13	-1.06	-0.65
Free Cash Flow per Basic Share	-2,098.42	-548.31	-445.04	-733.35	-245.23	-1.48	87.03	-127.02	-51.66	-33.1	-13	-1.07	-0.65
Cash & Equivalents per Share	6,457.18	1,665.13	737.84	488.63	388.16	286.88	312.56	163.16	78.24	8.45	1.79	2.77	2.7
Book Value per Share	6,774.49	1,746.95	739.64	435.48	443.05	307.12	-2,160.23	-1,941.67	-514.97	-308.57	-121.15	-10.36	-6.3
Tangible Book Value per Share	6,906.48	1,780.99	808.66	504.13	480.44	333.68	329.27	170.43	79.19	6	0.15	2.57	2.69

Benitec Biopharma Inc.

Profitability (AUD)

Credit (AUD)

Liquidity (AUD)

Working Capital (AUD)

Enterprise Value (AUD)

Multiples (AUD)

Per Share Data Items (AUD)